World Courier expands as Moscow becomes 'increasing popular destination'

By Melissa Fassbender contact

- Last updated on GMT

Experts predict the number of clinical trials in Russia could double by 2020. (Image: iStock/Lehtinen)
Experts predict the number of clinical trials in Russia could double by 2020. (Image: iStock/Lehtinen)

Related tags: Medicine

World Courier is set to open a new Moscow, Russia-based investigational drug depot in August – and it will be nearly six times larger than the current depot.

The new facility will provide temperature-controlled solutions and distribution needs, and a variety of new services, including local sourcing of comparator drugs and secondary packaging and labeling.

The facility will also be licensed to support commercial 3PL distribution for specialty products and features an expanded storage area. It will be staffed by full-time pharmacists.

According to World Courier President John Butler, the decision to add a new Moscow facility is a direct result of customers’ evolving and growing demand for high-quality solutions in that market.

Moscow has become an increasingly popular destination for pharmaceutical manufacturers seeking to conduct clinical trials outside the United States and Western Europe​,” Butler told

The market boasts a highly-urbanized healthcare system, trained medical personnel, lower costs and high patient recruitment and retention rates."

According to the company, of the 123 new drug therapies approved in 2015 by the Center for Drug Evaluation and Research, 50 were studied in Russia. Additionally, the number of clinical trials in Russia is predicted to double by 2020.

Butler said the company is seeing demand across the globe increase as pharmaceutical manufacturers become “more savvy with global commercialization plans​.”

In addition to Russia, World Courier has expanded in Israel and Australia, and AmerisourceBergen is working with Profarma, a specialty distributor in Brazil.

What we’re finding commonly in the these markets is a supportive environment for pharmaceutical research & development as well as patients that desire innovative technology and economies that are driving advances in healthcare​,” said Butler.

Related news

Show more

Related products

show more

Import Risks & Clinical Supply Depots

Import Risks & Clinical Supply Depots

Catalent Pharma Solutions | 07-Nov-2018 | Case Study

A sponsor running a clinical trial in Israel arranged to ship their clinical trial product from Europe to a depot in Israel. With the protocol based in...

Discover Fermion’s new API unit 4 in Hanko

Discover Fermion’s new API unit 4 in Hanko

Recorded the 04-Sep-2018 | Webinar

Join this webinar to learn more about Fermion’s new manufacturing unit 4 at the Hanko site. This webinar will provide virtual tour to our new state of...

Related suppliers

Follow us


View more